Skip to content

Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-506604-18-00
Acronym
SGNPDL1V-00
Enrollment
168
Registered
2023-10-06
Start date
2024-02-14
Completion date
Unknown
Last updated
2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer, Head and neck squamous cell carcinoma, Malignant melanoma, Non-small cell lung cancer, Oesophageal squamous cell carcinoma, Ovarian cancer, Squamous cell carcinoma of head and neck, Triple negative breast cancer

Interventions

None listed

Sponsors

Seagen Inc.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Belgium, France, Germany, Italy, Netherlands, Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026